UCL (University College London)
This course offers a comprehensive guide to all aspects of modern day drug design. It is taught by research scientists, clinicians and industry experts. Our graduates have progressed to undertake or obtain PhD's or medical studentships, or have found employment in both the private and public sector.
A minimum of a 2nd Class Honours degree in a relevant subject from a UK university or an overseas qualification of an equivalent standard.
Core modules: bioinformatics and structural biology; target identification and high throughput screening; cheminformatics and computer drug design; biological molecules as therapeutics - antibodies, siRNA, and stem cells; biophysical screening methods, protein NMR and phenotypic screening; fragment based drug design (FBDD); target selection (scientific grounds); target selection (commercial and intellectual property).
The programme is delivered through a combination of lectures, tutorials, self study, practical sessions and discussion groups. The research project forms one third of the programme. Each of the taught modules is assessed by unseen written examination (50 percent) and coursework (50 percent). The research project is assessed by the dissertation and viva.
|Qualification||Study mode||Fee||Course duration|
|MSc||Full-time||£ 12,310 per Academic year (home fees)||1 years|
|MSc||Full-time||£ 23,440 per Academic year (overseas fees)||1 years|
|MSc||Distance learning (full-time)||-||1 years|
|MSc||Distance learning||-||3 years|
|Campus name||Town||Postcode||Region||Main campus||Campus||Partner|
|Bloomsbury Campus||Camden||WC1E 6BT||South East|
020 7679 6710